hydroxychloroquine has been researched along with Left Ventricular Dysfunction in 6 studies
Hydroxychloroquine: A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970)
hydroxychloroquine : An aminoquinoline that is chloroquine in which one of the N-ethyl groups is hydroxylated at position 2. An antimalarial with properties similar to chloroquine that acts against erythrocytic forms of malarial parasites, it is mainly used as the sulfate salt for the treatment of lupus erythematosus, rheumatoid arthritis, and light-sensitive skin eruptions.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Two years prior to admission to our hospital, she had been diagnosed with rheumatoid arthritis and treated with hydroxychloroquine (HCQ) with a cumulative dose of 164 g." | 7.78 | Hydroxychloroquine-induced cardiomyopathy that presented as pulmonary hypertension: a newly noted complication. ( Bae, SM; Chin, JY; Ihm, SM; Jung, HO; Kim, JJ; Kim, TS; Lee, KY; Park, SH; Youn, HJ, 2012) |
| " Two years prior to admission to our hospital, she had been diagnosed with rheumatoid arthritis and treated with hydroxychloroquine (HCQ) with a cumulative dose of 164 g." | 3.78 | Hydroxychloroquine-induced cardiomyopathy that presented as pulmonary hypertension: a newly noted complication. ( Bae, SM; Chin, JY; Ihm, SM; Jung, HO; Kim, JJ; Kim, TS; Lee, KY; Park, SH; Youn, HJ, 2012) |
| "A 39-year-old woman with a history of systemic lupus erythematosus developed chest pain and conduction abnormalities." | 1.33 | Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction. ( Amin, S; Bhatia, S; Edwards, WD; Keating, RJ; Sinak, LJ; Williams, A, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Jacquet-Lagrèze, M | 1 |
| Riad, Z | 1 |
| Hugon-Vallet, E | 1 |
| Ferraris, A | 1 |
| Fellahi, JL | 1 |
| Geisler, BP | 1 |
| Kingsley, TC | 1 |
| Izmirly, PM | 1 |
| Costedoat-Chalumeau, N | 1 |
| Roswell, RO | 1 |
| Houssen, ME | 1 |
| El-Mahdy, RH | 1 |
| Shahin, DA | 1 |
| Abbasi, S | 1 |
| Tarter, L | 1 |
| Farzaneh-Far, R | 1 |
| Farzaneh-Far, A | 1 |
| Bae, SM | 1 |
| Jung, HO | 1 |
| Ihm, SM | 1 |
| Kim, JJ | 1 |
| Chin, JY | 1 |
| Kim, TS | 1 |
| Park, SH | 1 |
| Youn, HJ | 1 |
| Lee, KY | 1 |
| Keating, RJ | 1 |
| Bhatia, S | 1 |
| Amin, S | 1 |
| Williams, A | 1 |
| Sinak, LJ | 1 |
| Edwards, WD | 1 |
1 review available for hydroxychloroquine and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Left ventricular dysfunction in COVID-19: A diagnostic issue.
Topics: Azithromycin; Betacoronavirus; Biomarkers; Coronavirus Infections; COVID-19; Cytokine Release Syndro | 2020 |
5 other studies available for hydroxychloroquine and Left Ventricular Dysfunction
| Article | Year |
|---|---|
Hydroxychloroquine Toxicity: Concurrent Complete Heart Block and Severe Left Ventricular Systolic Dysfunction. A Clinical Image.
Topics: Heart Block; Heart Failure; Humans; Hydroxychloroquine; Stroke Volume; Ventricular Dysfunction, Left | 2021 |
Serum soluble toll-like receptor 2: a novel biomarker for systemic lupus erythematosus disease activity and lupus-related cardiovascular dysfunction.
Topics: Adrenal Cortex Hormones; Adult; Antirheumatic Agents; Biomarkers; Case-Control Studies; Creatinine; | 2016 |
Hydroxychloroquine: a treatable cause of cardiomyopathy.
Topics: Antirheumatic Agents; Biopsy; Cardiomyopathies; Coronary Angiography; Diagnosis, Differential; Dyspn | 2012 |
Hydroxychloroquine-induced cardiomyopathy that presented as pulmonary hypertension: a newly noted complication.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cardiac Catheterization; Cardiomyopathies; Female; Huma | 2012 |
Hydroxychloroquine-induced cardiotoxicity in a 39-year-old woman with systemic lupus erythematosus and systolic dysfunction.
Topics: Cardiomyopathies; Female; Humans; Hydroxychloroquine; Lupus Erythematosus, Systemic; Middle Aged; Ve | 2005 |